Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_25709 | 23 | 0.47 | Mlig455_034674, Mlig455_034724 | Neo: - Age: - |
CSTB | Mlig455_034674 {REF} {Length: 1369} {TRANSSPLICED} {Pfam: Cystatin domain [PF00031.23, score=27.9]} {Human: ENSG00000160213, CSTB, cystatin B, [Score=77.4, Expect=1e-19]} {Mouse: ENSMUSG00000005054, Cstb, cystatin B, [Score=69.7, Expect=1e-16]} {Smed: dd_Smed_v6_423_0_1, dd_Smed_v6_423_0_1, [Score=83.2, Expect=7e-22]} {RNA1509_48375} {RNA1310_25872} {RNA815_28693} Mlig455_034724 {REF} {Length: 533} {Pfam: Cystatin domain [PF00031.23, score=26.1]} {Human: ENSG00000160213, CSTB, cystatin B, [Score=71.6, Expect=2e-17]} {Mouse: ENSMUSG00000005054, Cstb, cystatin B, [Score=66.2, Expect=1e-15]} {Smed: dd_Smed_v6_423_0_1, dd_Smed_v6_423_0_1, [Score=68.6, Expect=2e-16]} {RNA1509_48375} {RNA1310_25872} {RNA815_14000} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -2.611 | 0.721 | 1.00000 | 1.00000 | |
RegionR2 | -0.689 | 0.721 | 0.99772 | 1.00000 | |
RegionR3 | -1.191 | 0.721 | 0.99222 | 1.00000 | |
RegionR4 | 3.182 | 0.721 | 0.15772 | 0.41318 | |
RegionR5 | 1.72 | 0.721 | 0.28251 | 0.61158 | |
RegionR6 | -3.214 | 0.721 | 1.00000 | 1.00000 | |
RegionR7 | 1.057 | 0.721 | 0.49787 | 1.00000 | |
RegionR8 | 1.746 | 0.721 | 0.77973 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | 0.054 | 0.721 | 0.99981 | 1.00000 | |
RegenerationR2 | -3.13 | 0.721 | 0.29490 | 0.73723 | |
RegenerationR3 | -3.674 | 0.721 | 0.16910 | 0.60335 | |
RegenerationR4 | -2.899 | 0.721 | 0.23883 | 0.68806 | |
RegenerationR5 | -4.612 | 0.721 | 0.06230 | 0.39617 | |
RegenerationR6 | -1.428 | 0.721 | 1.00000 | 1.00000 | |
RegenerationBL | -3.646 | 0.721 | 1.00000 | 1.00000 | |
RegenerationTP | -5.51 | 0.721 | 0.13987 | 0.55838 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_25709 | 23 | 0.47 | Mlig455_034674, Mlig455_034724 | Neo: - Age: - |
CSTB | 1 | - | - | - | 1.000 | - | - | Mlig455_034674 {REF} {Length: 1369} {TRANSSPLICED} {Pfam: Cystatin domain [PF00031.23, score=27.9]} {Human: ENSG00000160213, CSTB, cystatin B, [Score=77.4, Expect=1e-19]} {Mouse: ENSMUSG00000005054, Cstb, cystatin B, [Score=69.7, Expect=1e-16]} {Smed: dd_Smed_v6_423_0_1, dd_Smed_v6_423_0_1, [Score=83.2, Expect=7e-22]} {RNA1509_48375} {RNA1310_25872} {RNA815_28693} Mlig455_034724 {REF} {Length: 533} {Pfam: Cystatin domain [PF00031.23, score=26.1]} {Human: ENSG00000160213, CSTB, cystatin B, [Score=71.6, Expect=2e-17]} {Mouse: ENSMUSG00000005054, Cstb, cystatin B, [Score=66.2, Expect=1e-15]} {Smed: dd_Smed_v6_423_0_1, dd_Smed_v6_423_0_1, [Score=68.6, Expect=2e-16]} {RNA1509_48375} {RNA1310_25872} {RNA815_14000} |
2. | MligTC455_32913 | 38 | 0.79 | Mlig455_063646 | Neo: - Age: Down-Up-Down |
1 | - | - | - | 1.000 | - | - | Mlig455_063646 {REF} {Length: 2461} {RNA1509_54756} {RNA1310_15352} {RNA815_19591} | |
3. | MligTC455_37592 | 21 | 0.45 | Mlig455_024823, Mlig455_024904, Mlig455_025343 | Neo: - Age: - |
0.992 | - | - | - | 0.992 | - | - | Mlig455_024823 {REF} {Length: 89} {NoTransDecoderORF} Mlig455_024904 {REF} {Length: 89} {NoTransDecoderORF} Mlig455_025343 {REF} {Length: 1768} {NoTransDecoderORF} {RNA1509_57805} {RNA1310_26676} {RNA815_51492} |
|
4. | MligTC455_20286 | 108 | 2.26 | Mlig455_030205, Mlig455_047002, Mlig455_067144 | Neo: Int S/G2/M Age: Down-Down-Down, logFC(26M/2M)=-1.418 Region-enriched R4: 4.785/0.00002 |
0.971 | - | - | - | 0.971 | - | - | Mlig455_030205 {REF} {Length: 4304} {RNA1509_33227} {RNA1310_15319} {RNA815_20927} Mlig455_047002 {REF} {Length: 579} {RNA1310_15319} {RNA815_20927} Mlig455_067144 {REF} {Length: 572} {RNA1509_33227} {RNA1310_9578.1} {RNA815_50129} |
|
5. | MligTC455_10067 | 15 | 0.31 | Mlig455_049299, Mlig455_050636 | Neo: - Age: - Region-enriched R4: 7.033/0.01042 |
0.964 | - | - | - | 0.964 | - | - | Mlig455_049299 {REF} {Length: 374} {NoTransDecoderORF} {RNA1310_115820} Mlig455_050636 {REF} {Length: 548} {NoTransDecoderORF} {RNA1310_115820} |
|
6. | MligTC455_42831 | 85 | 1.77 | Mlig455_039919, Mlig455_041211, Mlig455_041225 | Neo: - Age: - |
BCL11A | 0.958 | - | - | - | 0.958 | - | - | Mlig455_039919 {REF} {Length: 2448} {Pfam: Zinc finger, C2H2 type [PF00096.28, score=48.7]; C2H2-type zinc finger [PF13894.8, score=30.4]; Zinc-finger double domain [PF13465.8, score=28.8]; C2H2-type zinc-finger domain [PF13909.8, score=19.3]} {Human: ENSG00000119866, BCL11A, B cell CLL/lymphoma 11A, [Score=152, Expect=6e-39]; ENSG00000127152, BCL11B, B cell CLL/lymphoma 11B, [Score=151, Expect=6e-39]} {Mouse: ENSMUSG00000000861, Bcl11a, B cell CLL/lymphoma 11A (zinc finger protein), [Score=152, Expect=4e-39]; ENSMUSG00000048251, Bcl11b, B cell leukemia/lymphoma 11B, [Score=151, Expect=4e-39]} {Dmel: FBgn0029939, CG9650, [Score=153, Expect=1e-39]} {Celegans: WBGene00017430, bcl-11, Mammalian BCL (B cell lymphoma) gene homologs, [RH, Score=131, Expect=1e-32]} {Smed: dd_Smed_v6_13341_0_1, dd_Smed_v6_13341_0_1, [Score=159, Expect=8e-43]} {RNA1509_16620} {RNA1310_48848} {RNA815_19660} Mlig455_041211 {REF} {Length: 2991} {Pfam: Zinc finger, C2H2 type [PF00096.28, score=48.7]; C2H2-type zinc finger [PF13894.8, score=30.4]; Zinc-finger double domain [PF13465.8, score=28.8]; C2H2-type zinc-finger domain [PF13909.8, score=19.3]} {Human: ENSG00000119866, BCL11A, B cell CLL/lymphoma 11A, [Score=152, Expect=6e-39]; ENSG00000127152, BCL11B, B cell CLL/lymphoma 11B, [Score=151, Expect=6e-39]} {Mouse: ENSMUSG00000000861, Bcl11a, B cell CLL/lymphoma 11A (zinc finger protein), [Score=152, Expect=4e-39]; ENSMUSG00000048251, Bcl11b, B cell leukemia/lymphoma 11B, [Score=151, Expect=4e-39]} {Dmel: FBgn0029939, CG9650, [Score=153, Expect=1e-39]} {Celegans: WBGene00017430, bcl-11, Mammalian BCL (B cell lymphoma) gene homologs, [RH, Score=131, Expect=1e-32]} {Smed: dd_Smed_v6_13341_0_1, dd_Smed_v6_13341_0_1, [Score=159, Expect=8e-43]} {RNA1509_16620} {RNA1310_48848} {RNA815_19660} Mlig455_041225 {REF} {Length: 3047} {Pfam: Zinc finger, C2H2 type [PF00096.28, score=48.7]; C2H2-type zinc finger [PF13894.8, score=30.4]; Zinc-finger double domain [PF13465.8, score=28.8]; C2H2-type zinc-finger domain [PF13909.8, score=19.3]} {Human: ENSG00000119866, BCL11A, B cell CLL/lymphoma 11A, [Score=152, Expect=6e-39]; ENSG00000127152, BCL11B, B cell CLL/lymphoma 11B, [Score=151, Expect=6e-39]} {Mouse: ENSMUSG00000000861, Bcl11a, B cell CLL/lymphoma 11A (zinc finger protein), [Score=152, Expect=4e-39]; ENSMUSG00000048251, Bcl11b, B cell leukemia/lymphoma 11B, [Score=151, Expect=4e-39]} {Dmel: FBgn0029939, CG9650, [Score=153, Expect=1e-39]} {Celegans: WBGene00017430, bcl-11, Mammalian BCL (B cell lymphoma) gene homologs, [RH, Score=131, Expect=1e-32]} {Smed: dd_Smed_v6_13341_0_1, dd_Smed_v6_13341_0_1, [Score=159, Expect=8e-43]} {RNA1509_16620} {RNA1310_48848} {RNA815_19660} |
7. | MligTC455_06647 | 17 | 0.35 | Mlig455_009519 | Neo: - Age: - |
0.951 | - | - | - | 0.951 | - | - | Mlig455_009519 {REF} {Length: 591} {NoTransDecoderORF} {RNA1509_15304} {RNA1310_149116} {RNA815_5012.1} | |
8. | MligTC455_09333 | 26 | 0.53 | Mlig455_068268 | Neo: - Age: - |
DMD | 0.951 | - | - | - | 0.951 | - | - | Mlig455_068268 {REF} {Length: 877} {Human: ENSG00000198947, DMD, dystrophin, [Score=69.3, Expect=2e-13]} {Mouse: ENSMUSG00000045103, Dmd, dystrophin, muscular dystrophy, [Score=69.3, Expect=1e-13]} {Dmel: FBgn0260003, Dys, Dystrophin, [Score=74.7, Expect=2e-15]} {Smed: dd_Smed_v6_5325_0_3, dd_Smed_v6_5325_0_3, [Score=52.4, Expect=5e-08]} {RNA815_52262} |
9. | MligTC455_19966 | 28 | 0.59 | Mlig455_007419 | Neo: - Age: Up-Down-Down |
0.951 | - | - | - | 0.951 | - | - | Mlig455_007419 {REF} {Length: 1601} {NoTransDecoderORF} {RNA1509_51785} {RNA1310_77392} {RNA815_14770.1} | |
10. | MligTC455_34016 | 46 | 0.96 | Mlig455_006455 | Neo: - Age: logFC(26M/2M)=0.497 |
MX2 | 0.951 | - | - | - | 0.951 | - | - | Mlig455_006455 {REF} {Length: 3014} {Pfam: Dynamin family [PF00350.25, score=111.5]; Dynamin central region [PF01031.22, score=36.1]; 50S ribosome-binding GTPase [PF01926.25, score=24.0]} {Human: ENSG00000183486, MX2, MX dynamin like GTPase 2, [Score=150, Expect=6e-38]} {Mouse: ENSMUSG00000023341, Mx2, MX dynamin-like GTPase 2, [Score=145, Expect=1e-36]; ENSMUSG00000000386, Mx1, MX dynamin-like GTPase 1, [Score=141, Expect=1e-37]} {Dmel: FBgn0003392, shi, shibire, [Score=110, Expect=6e-25]} {Celegans: WBGene00001130, dyn-1, Dynamin, [Score=102, Expect=1e-22]} {Smed: dd_Smed_v6_2583_0_1, dd_Smed_v6_2583_0_1, [Score=107, Expect=3e-24]} {RNA1310_33314} {RNA815_28377} |
11. | MligTC455_38160 | 5 | 0.1 | Mlig455_023435 | Neo: - Age: - |
PKD2L1 | 0.951 | - | - | - | 0.951 | - | - | Mlig455_023435 {REF} {Length: 4742} {Pfam: Polycystin cation channel [PF08016.14, score=168.5]; Ion transport protein [PF00520.33, score=29.2]} {Human: ENSG00000107593, PKD2L1, polycystin 2 like 1, transient receptor potential cation channel, [Score=114, Expect=9e-26]} {Mouse: ENSMUSG00000037578, Pkd2l1, polycystic kidney disease 2-like 1, [Score=120, Expect=5e-28]} {Dmel: FBgn0040333, brv3, brivido-3, [Score=67.8, Expect=2e-11]} {Celegans: WBGene00003058, lov-1, Location of vulva defective 1, [Score=114, Expect=6e-26]} {Smed: dd_Smed_v6_17348_0_1, dd_Smed_v6_17348_0_1, [Score=136, Expect=2e-33]} {RNA1509_36495} {RNA1310_14058} {RNA815_29106} |
12. | MligTC455_05836 | 41 | 0.86 | Mlig455_062933 | Neo: - Age: - |
GLRA3 | 0.95 | - | - | - | 0.950 | - | - | Mlig455_062933 {REF} {Length: 2405} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=115.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=75.9]} {Human: ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=186, Expect=5e-53]; ENSG00000145888, GLRA1, glycine receptor alpha 1, [Score=179, Expect=2e-50]} {Mouse: ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [Score=182, Expect=2e-51]; ENSMUSG00000000263, Glra1, glycine receptor, alpha 1 subunit, [Score=179, Expect=1e-50]; ENSMUSG00000018595, Glra4, glycine receptor, alpha 4 subunit, [Score=177, Expect=6e-50]; ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=177, Expect=5e-50]; ENSMUSG00000029212, Gabrb1, gamma-aminobutyric acid (GABA) A receptor, subunit beta 1, [Score=173, Expect=4e-48]} {Dmel: FBgn0024963, GluClalpha, [Score=178, Expect=1e-50]} {Celegans: WBGene00001591, glc-1, Glutamate-gated chloride channel alpha, [Score=193, Expect=5e-56]} {Smed: dd_Smed_v6_11342_0_1, dd_Smed_v6_11342_0_1, [Score=197, Expect=7e-58]} {RNA1310_58187} |